CathWorks is a medical equipment manufacturing company with a United States headquarters in Newport Beach, California, dedicated to improving patient health by transforming cardiovascular procedures with its FFRangio System.
Subscribe to see Cathworks’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cathworks is a medical devices company headquartered in Israel, founded in 2013. It has raised at least $75.8M across the 3 funding rounds on record. Its most recent funding round, Series D, raised $30M in January 2021.
At least $75.8M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series D | $30M | — | |
| — | $30M | — | |
| Series B | $15.8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Cathworks's closest competitors — see the full list of competitors and alternatives →
Flow Forward Medical develops an all-in-one, steerable catheter system designed for interventional pulmonary embolism treatment, combining angiography, infusion, and real-time monitoring capabilities. The company serves medical providers by streamlining procedures, optimizing lytic delivery, and tracking clot resolution to improve patient outcomes.
Rainmed Medical Limited is a medical technology firm specializing in the creation, development, and market launch of advanced systems that utilize coronary angiography to assess fractional flow reserve (FFR) and the index of microvascular resistance (IMR). Its offerings include the FlashAngio caFFR System, which accurately determines FFR values by reconstructing a three-dimensional model of the coronary arterial system from two angiographic images. Additionally, the company provides the FlashAngio caIMR System, an innovative non-invasive solution for the diagnosis and treatment of microcirculatory lesions. Rainmed Medical is also engaged in pioneering intelligent angiographic injection technologies, robotic navigation systems for vascular interventions, and flash renal denervation solutions. Established in 2014, the company is headquartered in Suzhou, China.
PuraCath Medical, Inc. is a medical device company focused on vascular access solutions. Headquartered in Newark, California, the company develops specialized technologies to improve safety and outcomes for patients requiring vascular access.
Headquartered in Awans, Belgium, CryoTherapeutics develops catheter-based intravascular cryotherapy technology designed to stabilize vulnerable coronary plaques by reducing inflammation.
Conavi Medical Corp. manufactures and sells the Novasight Hybrid System, a medical device that combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging using a single catheter and pullback. The system is designed for cardiologists and healthcare providers to visualize coronary arteries, assess plaque burden, and evaluate stents during percutaneous coronary interventions (PCIs).
Contego Medical, Inc. is a medical equipment manufacturing company headquartered in Raleigh, North Carolina, focused on developing advanced vascular devices designed to simplify complex interventional procedures.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.